Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102277392B details enzymatic resolution for high-purity pharmaceutical intermediates. Offers significant cost reduction and supply chain reliability for global buyers.
Patent CN110423219A reveals aqueous resolution for high-purity R-tetrahydropapaverine. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101838282B details a cost-effective resolution method for 4-AA, avoiding expensive catalysts for reliable pharmaceutical intermediate supply.
Patent CN118255768A details high-purity Ruxolitinib synthesis via chiral resolution. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN109553610A details a novel six-step synthesis for emtricitabine isomers offering high purity and scalable manufacturing processes for global supply chains.
Novel patent CN103664887B enables high-purity Esomeprazole Sodium production. Eliminating toxic solvents ensures cost reduction and supply chain reliability for global pharmaceutical partners.
Patent CN110467557A reveals a high-yield one-pot synthesis for Apremilast. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN103214487A reveals stable synthesis route. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Novel preparation method for Silodosin intermediate via CN104974072A. Offers cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN106660949B reveals a safe, scalable chiral resolution method for TRPV1 antagonist intermediates, offering significant cost reduction in API manufacturing.
Patent CN104164470B details a novel DKR method for R-1-naphthylethylamine using Raney Nickel. This approach ensures high yield and purity for reliable pharmaceutical intermediates supply chains.
Patent CN104151171B details nickel-catalyzed dynamic kinetic resolution for high yield chiral amine production ensuring supply chain stability and cost efficiency.
Patent CN1115343C details a novel enzymatic route for chiral cyclopentene amines, offering cost-effective API intermediate manufacturing with high enantiomeric purity.
Novel asymmetric acetal method for (1R,5S)-3-ethylbicyclo[3.2.0]hept-3-en-6-one synthesis. High ee%, low cost, scalable process for API manufacturing.
Patent CN105017035B details a high-purity DKR method for chiral intermediates. Achieves >99% ee with scalable catalysts for reliable pharmaceutical supply chains.
Novel chiral resolution method for Tetrabenazine using di-p-methylbenzoyltartaric acid. Achieves >99% ee with scalable crystallization for reliable API intermediate supply.
Patent CN102850204B details advanced chiral resolution for NSAIDs. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.
Novel water-based resolution method for S-3-aminopiperidine. High purity 99.5% yield 72%. Cost-effective pharmaceutical intermediate supply chain solution.
Patent CN111909067B reveals a novel 5-step total synthesis of D-penicillamine from L-serine, offering high optical purity and scalable production for pharmaceutical supply chains.
Discover the advanced synthesis of (1S)-4,5-dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride. A cost-effective, scalable route for pharmaceutical supply chains.